Skip to content

Functional Predictive Value of Collective Outcome Measure(s) Status Post Total Hip/Knee Arthroplasty

Functional Predictive Value of Collective Outcome Measure(s) Status Post Total Hip/Knee Arthroplasty

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03933969
Enrollment
26
Registered
2019-05-01
Start date
2019-06-11
Completion date
2022-12-23
Last updated
2023-01-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Joint Arthroplasty, Knee and Hip

Brief summary

Researchers are trying to assess a predictive value or correlation of outcome measures results on subjects following a total knee or total hip arthroplasty in order to better predict the time frame taken to achieve certain functional milestones that are pertinent to subject population.

Detailed description

Subjects will undergo testing for a normal physical therapy clinical assessment that is standard of care for anyone who has a total hip or total knee surgery. Researchers will be using the data obtained from standard therapy care and see if correlations exist from that data and the time taken to complete specific functional tasks.

Interventions

None listed

Sponsors

Mayo Clinic
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Patient's 18 years or older * Patients who recently underwent a primary total hip or total knee arthroplasty * Patient who recently underwent a total hip or total knee revision

Exclusion criteria

* Patients who lack the ability to provide informed consent * Patients with previous total joint replacement within the last 6 months * Patients with complications following surgery such as DVT/PE/Infection

Design outcomes

Primary

MeasureTime frameDescription
Assistive Device WeaningApproximately 3 monthsNumber of days to weaning from all assistive devices

Secondary

MeasureTime frameDescription
Weaning from pain medication, ability to reciprocally use steps, ability to walk 1 mile or 30 minutes consecutivelyApproximately 3-6 monthsNumber of days taken to achieve milestones

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026